Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.

• Main Authors: Mereckiene J, Cotter S, Weber JT, Nicoll A, D'Ancona F, Johansen K, Wasley AM, Jorgensen P, Lévy Bruhl D, Giambi C, Stefanoff P, Dematte L, O'Flanagan D, VENICE project gatekeepers group, LOPALCO, PIETRO LUIGI
• Other Authors: Mereckiene, J, Cotter, S, Weber, Jt, Nicoll, A, D'Ancona, F, Lopalco, PIETRO LUIGI, Johansen, K, Wasley, Am, Jorgensen, P, Lévy Bruhl, D, Giambi, C, Stefanoff, P, Dematte, L, O'Flanagan, D, VENICE project gatekeepers, Group
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2012
• Subjects: Norway; Iceland
• Online Access: http://hdl.handle.net/11568/800002

In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.